What are the roles of testosterone and dihydrotestosterone (DHT) in spermatogenesis and male fertility?

Medical Advisory BoardAll articles are reviewed for accuracy by our Medical Advisory Board
Educational purpose only • Exercise caution as content is pending human review
Article Review Status
Submitted
Under Review
Approved

Last updated: November 17, 2026 • View editorial policy

Have a follow-up question?

Our Medical A.I. is used by practicing medical doctors at top research institutions around the world. Ask any follow up question and get world-class guideline-backed answers instantly.

Testosterone and DHT in Spermatogenesis

Testosterone is absolutely essential for initiating and maintaining spermatogenesis, while DHT can support spermatogenesis through the same androgen receptor pathway but is less effective than testosterone at maintaining quantitatively normal sperm production. Both androgens work through the androgen receptor in Sertoli cells, but high intratesticular testosterone concentrations—not achievable through exogenous administration—are specifically required for optimal sperm production 1, 2.

Critical Physiological Roles

Testosterone's Primary Functions

Testosterone drives spermatogenesis through multiple mechanisms:

  • Intratesticular concentration requirements: High local testosterone levels (15-20 ng/mL intratesticular) are necessary, far exceeding what's needed to saturate androgen receptors 3. This concentration cannot be replicated by systemic testosterone administration 2.

  • Sertoli cell activation: Testosterone binds selectively to androgen receptors within Sertoli cells, initiating and maintaining the spermatogenic process while simultaneously inhibiting germ cell apoptosis 2.

  • Germ cell development: Testosterone is required for the progression of all germ cell stages, from spermatogonia through mature spermatids 4, 5.

DHT's Supporting Role

DHT functions as a metabolite of testosterone with distinct properties:

  • Androgen receptor affinity: DHT has greater affinity for and slower dissociation from the androgen receptor compared to testosterone 3.

  • Limited spermatogenic capacity: Despite superior receptor binding, DHT maintains spermatogenesis only partially. In experimental models, DHT produced significantly lower testicular weights and fewer early spermatids than testosterone, with late spermatids present only in testosterone-treated animals 6.

  • Mechanism of limitation: The reduced efficacy stems from lower achievable intratesticular DHT concentrations compared to testosterone when administered systemically 6.

Clinical Implications for Fertility

Exogenous Testosterone Destroys Fertility

Testosterone therapy is absolutely contraindicated in men desiring fertility 7, 8. The mechanism is straightforward:

  • Exogenous testosterone suppresses GnRH from the hypothalamus and LH from the pituitary through negative feedback 2, 9.
  • This suppression eliminates endogenous Leydig cell testosterone production 9.
  • Without high intratesticular testosterone, spermatogenesis fails despite adequate systemic testosterone levels 2.
  • Recovery after cessation is highly variable (14 months for sperm count, up to 38 months for motility) and not guaranteed 9, 10.

Fertility Preservation Strategies

For hypogonadal men requiring treatment while preserving fertility:

  • Secondary hypogonadism: Use combined hCG and FSH therapy, which maintains intratesticular testosterone while supporting spermatogenesis 7, 8, 10.
  • Primary hypogonadism: Spermatogenesis cannot be stimulated with gonadotropins; options are limited to donor sperm, adoption, or testicular sperm extraction with assisted reproduction 8.

Androgen Receptor Dependency

Both testosterone and DHT require functional androgen receptors:

  • Complete androgen insensitivity results in absent spermatogenesis despite normal testosterone production 2.
  • Partial androgen receptor mutations reduce sperm counts proportionally to receptor dysfunction 10.
  • Animal models demonstrate that androgens acting through the androgen receptor can initiate qualitatively complete spermatogenesis even without FSH, though FSH optimizes the process 4, 5.

Common Clinical Pitfalls

Critical error: Prescribing testosterone replacement to men with unexplained infertility or low testosterone who haven't completed their families. Always assess fertility intentions before initiating testosterone therapy 7.

Anabolic steroid abuse: Men using supraphysiologic androgens for bodybuilding develop testicular atrophy and azoospermia through the same suppressive mechanism. Recovery is unpredictable and may require gonadotropin therapy 1, 9.

Misunderstanding DHT's role: While DHT is crucial for external genitalia development and secondary sexual characteristics, it cannot substitute for testosterone in maintaining normal spermatogenesis 1, 6.

Related Questions

After a transgender woman stops estradiol and spironolactone, how long does it take to regain spermatogenesis and produce sperm?
What are the functions of testosterone, the testes, and the prostate gland in males?
Which step of semen formation (spermatogenesis) is supported by testosterone?
I'm a male of reproductive age with normal testosterone levels, normal sperm parameters, and a normal Follicle-Stimulating Hormone (FSH) level, but I've noticed my testicles feeling soft and mushy for about a month, could I be experiencing ongoing testicular atrophy?
What post-cycle therapy (PCT) regimen can help a 5-year Testosterone Replacement Therapy (TRT) patient regain fertility and restore natural testosterone production?
In an eclampsia patient receiving magnesium sulfate infusion with target serum magnesium 4.8–8.4 mg/dL, urine output 100 ml/hr, serum magnesium 8 mg/dL while infusing 2 g/hr and creatinine 1.4 mg/dL, should the infusion be reduced to 1.5 g/hr and the level rechecked in four hours?
What is the definitive treatment for invasive squamous cell carcinoma of the ear?
For adult patients with neuropathic pain, generalized anxiety disorder, or fibromyalgia, how does pregabalin compare to merogabalin (mirogabalin) regarding FDA approval, dosing regimens, safety profile, and abuse potential?
What additional conservative mechanical interventions can be used to support a patient with a thoracolumbar (T12) vertebral fracture?
A patient with a urinary tract infection who has already received nitrofurantoin (Macrobid) and trimethoprim‑sulfamethoxazole (Bactrim) has a susceptibility report showing susceptibility to amoxicillin/clavulanic acid, cefazolin, cefepime, cefoxitin, cefpodoxime, ceftriaxone, ertapenem, gentamicin, meropenem, nitrofurantoin, and piperacillin/tazobactam, and resistance to ampicillin, ciprofloxacin, levofloxacin, tetracycline, and trimethoprim‑sulfamethoxazole. What is the appropriate antibiotic regimen for this patient?
What are the typical white blood cell, absolute lymphocyte, and absolute neutrophil counts in influenza pneumonia?

Professional Medical Disclaimer

This information is intended for healthcare professionals. Any medical decision-making should rely on clinical judgment and independently verified information. The content provided herein does not replace professional discretion and should be considered supplementary to established clinical guidelines. Healthcare providers should verify all information against primary literature and current practice standards before application in patient care. Dr.Oracle assumes no liability for clinical decisions based on this content.